Condition: Pancreatic Cancer · Pancreatic Ductal Adenocarcinoma · Pancreatic Intraepithelial Neoplasias · Sponsor: Changhai Hospital
Pancreatic ductal adenocarcinoma (PDAC) remains a therapeutic challenge with 5-year survival rates of 13%, primarily attributable to advanced-stage diagnosis (AJCC Stage III/IV in \>80% of cases). This prospective, observational, multi-center study will evaluate the performance of an AI-powered opportunistic screening system utilizing non-contrast computed tomography (NCCT) acquired during routine clinical encounters or health check-ups. The proposed AI model will perform automated detection of pancreatic parenchymal abnormalities, including PDAC and precursor lesions (intraductal papillary mucinous neoplasms \[IPMN\], mucinous cystic neoplasms \[MCN\]). Algorithm-positive cases will be independently reviewed by two radiologists. Highly suspected individuals will undergo further diagnostic verification, including serological tests and multimodal imaging confirmation. Patients with confirmed positive diagnosis will receive multidisciplinary consultation and specialized treatment, whereas those with negative results will undergo at least one-year clinical follow-up. This study will quantitatively evaluate the AI system's performance, and aims to advance PDAC early detection, improve patient outcomes, and make it accessible in underserved populations.
This description comes directly from the study's public registry record.
Wang Bei Lei, M.D. · 86-13774238083 · lilly_wang@126.com
Guo Shi Wei, M.D. · 86-18621500666 · gestwa@163.com
Always discuss trial participation with your own doctor first.
| Shanghai Changhai Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Second Affiliated Hospital of Jiaxing University | Jiaxing, Zhejiang, China | Recruiting |
| Yinzhou Hospital Affiliated to Medical School of Ningbo University | Ningbo, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06638866